Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lutronic PICOPLUS Receives the CE Mark for its Validated 450 ps Pulse Width and is Featured in a Scientific Reports Article for its Proven Photoacoustic Effect
  • USA - English


News provided by

Lutronic Aesthetic INC.

Jul 17, 2017, 11:00 ET

Share this article

Share toX

Share this article

Share toX

GYEONGGI-DO, KOREA (PRWEB) July 18, 2017 -- Lutronic announces the receipt of CE marking for its faster PICOPLUS 450 ps pulse width and a new published paper entitled ‘Pattern analysis of laser-tattoo interactions for picosecond- and nanosecond-domain 1,064-nm neodymium-doped yttrium-aluminum-garnet lasers in tissue-mimicking phantom’ featured in Nature’s specialty journal Scientific Reports May 08, 2017. The paper focuses on comparing the dual picosecond (ps) and nanosecond (ns) pulsewidths featured in the PICOPLUS laser, which also features four wavelengths. The study outlined the macroscopic laser-tattoo interactions in tissue-mimicking (TM) phantoms treated with 1064 nm ps- and ns-domain laser energy, as well as exploring the reactions to multiple passes and combination of pulsewidths.

The authors of the article analyzed and compared patterns of laser-tattoo interactions using ps and ns pulsewidth Nd:YAG laser energy on a tattoo pigment-embedded TM phantom. Additionally, time-dependent interactions from laser irradiation to Photoacoustic Injury Zones formation in the simulated tissue surrounding the tattoo pigment were captured with high-speed cinematography.

Their experiments included:
• Effects of ps and ns Nd:YAG laser treatment on tattoo ink embedded in the TM phantoms.
• Combined treatment with ps and ns Nd:YAG lasers on tattoo ink embedded in the TM phantoms.
• High-speed cinematography of ps and ns Nd:YAG laser treatment of tattoo ink embedded in the TM phantoms.

Findings included:
• The core pigments of the baseline tattoos were more markedly fragmented and dispersed to the peripheral areas of the PIZs with the ps treatment than with the ns treatment.
• Disintegrated particles created during the ps treatment were more evenly distributed throughout the PIZs than the particles generated during the ns treatment.
• Laser-tattoo interactions were more significantly apparent with the combined ns-then-ps treatment than the combined ns-then-ns treatment.

“This scientific paper further demonstrates the effectiveness of the PICOPLUS. Although the ns pulsewidth works effectively to target tattoo ink, the ps pulsewidth is significantly more effective at breaking down the particles for more efficient absorption by the body,” stated Sungho Ko, Executive Managing Director, Lutronic. “Furthermore, the combined pass technique (ns-then ps) showed even more effective results than when using the single pulse width (ns-then-ns) alone.”

It was clearly evident from the article that, by utilizing the ps pulse width alone or in combination, a clearly efficacious advantage was demonstrated over using the ns pulsewidth alone. By providing improved disintegration of tattoo particles with ns-domain energy, smaller remnant particle sizes and even distribution of dispersed fragments support the body’s natural phagocytic processes to clear the pigment particles.

The upgraded PICOPLUS, which received its CE mark in June of this year, touts an improved 450 ps pulsewidth, while maintaining its maximum pulse energy; this equates to a 22% increase in power. In addition, the Picoplus 450 ps pulsewidth is the highest rated 450 ps device available. This improved power output is a key factor in the demonstrated performance shown by the findings in the Scientific Reports article in dermal pigmented lesions, including tattoos. At the other end of the energy spectrum, PICOPLUS offers the lowest stable pulse energies amongst all available ps-domain laser systems when using the 532 nm wavelength, an essential prerequisite for the safer and more effective treatment of well-circumscribed discrete epidermal pigmented lesions.

About PICOPLUS
The PICOPLUS platform offers both ps and ns modes with the performance of four wavelengths (1064, 532, 595 and 660 nm) to provide physicians with more options than ever before to address everything from standard treatments, to those hard to treat cases resistant to other Nd:YAG approaches. This CE-marked device delivers the customized power, pulsewidth, wavelength and fluence you need to achieve the outstanding outcomes that patients want, all from one premium platform. PICOPLUS represents the next generation on from our PICO+4.
• Four wavelengths for best versatility
• Dual pulse duration, ps- and ns-domains
• High energy output while still providing stable low energy output
• Pulsewidth 450 ps with maximum 800 mJ at 1064 nm: 1.78 GW peak power
• Dual treatment modes for optimized treatment options
• Wide-range of precisely controllable fluence options
• 5 handpieces (including Focused Dots)
• Convenience features, such as built-in storage

For more information about PICOPLUS visit: http://www.international.lutronic.com/picoplus

About LUTRONIC
Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 20 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, rejuvenation, body/face contouring, chronic pain, healing and more.

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenues to R&D, Lutronic holds more than 200 current and pending patents worldwide. With more than 270 employees worldwide, Lutronic has offices in the US, Europe, Korea, China, and Japan, a world-wide network of distributors, focused R&D centers in Korea, and is ever expanding.

For more information about Lutronic visit: http://www.lutronic.com

Okboon Jung, Lutronic Aesthetic INC., http://www.lutronic.com, +82 7047146081, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.